Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|14|1|61-70

ISSN： 1570-162X

Source： Current HIV Research, Vol.14, Iss.1, 2016-01, pp. : 61-70

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

SWIFT: Prospective 48-Week Study to Evaluate Efficacy and Safety of Switching to Emtricitabine/Tenofovir From Lamivudine/Abacavir in Virologically Suppressed HIV-1 Infected Patients on a Boosted Protease Inhibitor Containing Antiretroviral Regimen

By Campo R.   DeJesus E.   Bredeek U. F.   Henry K.   Khanlou H.   Logue K.   Brinson C.   Benson P.   Dau L.   Wang H.   White K.   Flaherty J.   Fralich T.   Guyer B.   Piontkowsky D.  

Clinical Infectious Diseases, Vol. 56, Iss. 11, 2013-06 ,pp. : 1637-1645

Oxford University Press

Access to resources Recommend Favorite

Quadruple Nucleos(t)ide Reverse Transcriptase Inhibitors-Only Regimen of Tenofovir Plus Zidovudine/Lamivudine/Abacavir in Heavily Pre-Treated HIV-1 Infected Patients: Salvage Therapy or Backbone Only?

By  

Current HIV Research, Vol. 7, Iss. 3, 2009-05 ,pp. : 320-326

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of advanced HIV disease in antiretroviral-naïve HIV-1-infected patients receiving once-daily atazanavir/ritonavir or twice-daily lopinavir/ritonavir, each in combination with tenofovir disoproxil fumarate and emtricitabine

By Uy Jonathan   Yang Rong   Wirtz Victoria   Sheppard Louise   Farajallah Awny   McGrath Donnie  

AIDS Care, Vol. 23, Iss. 11, 2011-11 ,pp. : 1500-1504

Routledge Ltd

Access to resources Recommend Favorite

Beliefs about antiretroviral therapy, treatment adherence and quality of life in a 48-week randomised study of continuation of zidovudine/lamivudine or switch to tenofovir DF/emtricitabine, each with efavirenz

By Cooper Vanessa   Moyle Graeme   Fisher Martin   Reilly Geraldine   Ewan Jacqueline   Liu Hui   Horne Rob  

AIDS Care, Vol. 23, Iss. 6, 2011-06 ,pp. : 705-713

Routledge Ltd

Access to resources Recommend Favorite

Health-related quality of life and patient-provider relationships in HIV-infected patients during the first three years after starting PI-containing antiretroviral treatment

By Préau M.   Leport C.   Salmon-ceron D.   Carrieri P.   Portier H.   Chene G.   Spire B.   Choutet P.   Raffi F.   Morin M.  

AIDS Care, Vol. 16, Iss. 5, 2004-07 ,pp. : 649-661

Routledge Ltd

Access to resources Recommend Favorite